Q3 Earnings Forecast for SAGE Issued By Leerink Partnrs
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Analysts at Leerink Partnrs issued their Q3 2025 earnings estimates for Sage Therapeutics in a research report issued to clients and investors on Tuesday, February 11th. Leerink Partnrs analyst M. Goodman expects that the biopharmaceutical company will post earnings per share of ($0.15) for the quarter. The […]
Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Analysts at Leerink Partnrs issued their Q3 2025 earnings estimates for Sage Therapeutics in a research report issued to clients and investors on Tuesday, February 11th. Leerink Partnrs analyst M. Goodman expects that the biopharmaceutical company will post earnings per share of ($0.15) for the quarter. The […]
